id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-3455-0005,FDA,FDA-2015-N-3455,Medical Devices: Exemption From Premarket Notification; Class II Devices; Autosomal Recessive Carrier Screening Gene Mutation Detection System,Rule,Final Rule,2017-11-07T05:00:00Z,2017,11,2017-11-07T05:00:00Z,,2017-11-07T15:25:39Z,2017-24162,0,0,0900006482c53e4a